Guidelines for Non-Small Cell Lung Cancer Customized Care 
 

Thursday, October 17, 2013

National Jewish Health
Molly Blank Conference Center
1400 Jackson St.
Denver, CO 80206

Register Online Now or call 800.844.2305 to register.
 


 

Goal and Purpose

The goal of this program is to improve patient care and professional knowledge in non-small cell lung cancer (NSCLC). Clinicians will learn to improve their ability to provide NSCLC therapies to all eligible populations; improve their knowledge and ability to apply guidelines and classification schemes for NSCLC; select NSCLC regimens based on molecular and histological markers; understand the challenges in tissue acquisition and management for morphological and molecular analysis.

This symposium will include interactive and multimedia lectures, case-based learning, and an innovative wrap-up session titled “Medical Survivor,” which will feature a panel of four key opinion leaders for a fun case-based interaction with the audience. 

 

Conference Objectives

Upon completion of this conference, the participant will be better able to:

  1. Discuss guidelines for lung cancer screening and address recent information identifying who should and who should not be screened and how to go about screening. 
  2. Review advances in minimally invasive diagnostic techniques. Outline the optimal methods for the minimally invasive acquisition and efficient processing of malignant tissue for morphological and molecular analysis.
  3. Discuss role and guidelines for molecular analysis/molecule pathology as a guide to diagnose and treat lung cancer. 
  4. Review current advances in individual care for lung cancer.

 
Conference Agenda

Time Topic
5:30-6:00 p.m. 
Registration
6:00-6:15 p.m.
Welcome & Introductions & Pre-Test
6:15-6:40 p.m.
Current Status of CT Screening for Lung Cancer
6:40-7:05 p.m.
Radiologic Work Up of Nodules and Diagnosis of Lung Cancer
7:05-7:30 p.m.
Treatment of NSCLC - Minimally Invasive Diagnostic Techniques
7:30-8:00 p.m.
Challenges in the Clinical Application of Molecular Profiling -
Molecular Pathology as a Guide to Diagnosis and Care
8:00-8:30 p.m.
Medical Survivor - panel will defend lung cancer-related
patient case
8:30-8:40 p.m.
Post-Test and Evaluations

Download the full AGENDA

 

Register Online Now or call 800.844.2305 to register.

 

Program Faculty

Jeffrey Kern, MD (Program Chair)
Chief, Division of Oncology, Cancer Center
Director, Lung Cancer Center
Professor
Department of Medicine
National Jewish Health

James R. Jett, MD
Director, Clinical and Translational Research Section
Professor
Department of Medicine
Division of Oncology, Cancer Center
National Jewish Health

David A. Lynch, MD
Professor
Office of Academic Affairs
Division of Radiology
National Jewish Health

Ali Musani, MD, FACP, FCCP
Director, Interventional Pulmonology
Associate Professor
Department of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health

Laurie L. Carr, MD
Assistant Professor
Department of Medicine
Division of Oncology, Cancer Center
National Jewish Health


Who Should Attend

The target audiences for this program are pulmonologists, pathologists, oncologists, physician assistants, nurse practitioners, nurses, and other health care professionals who treat patients with NSCLC.


Registration Information

NO FEE, conference materials and dinner are provided.

Register Online Now or call 800.844.2305 to register.
 

Accreditation and Designation Statements

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. National Jewish Health designates this live educational activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education: National Jewish Health® is a provider approved by the California Board of Registered Nursing, Provider Number CEP 12724. This program is accredited for 3.2 Nursing Contact Hours.  Participant attendance throughout the entire presentation is required to receive contact hours. 


This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
 

Register Online Now or call 800.844.2305 to register.
 

Continuing Medical Education Disclaimer

National Jewish Health (NJH) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, "NJH Parties") shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.

By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.

Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

CME/CE OPPORTUNITIES 


Best Practice in Collaboration Award
 
The Office of Professional Education was awarded the 2012 Best Practice in Collaboration Award at the Colorado Alliance of Continuing Medical Education (CACME) Annual Meeting. Read more.